TsewangTashiMD
Hematology • Salt Lake City, UTHematologic Oncology, Myeloproliferative Disorder Hematology-Oncology
Assistant Professor, Division of Hematology & Hematologic Malignancies, Huntsman Cancer Institute, University of Utah
Dr. Tashi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1950 Circle of Hope Dr
Salt Lake City, UT 84112Phone+1 801-585-3229Fax+1 801-585-3854- Is this information wrong?
Education & Training
University of Utah HealthFellowship, Hematology and Medical Oncology, 2012 - 2015
Creighton University School of Medicine (Omaha)Residency, Internal Medicine, 2008 - 2011
Chang Gung University College of MedicineClass of 2003, MD
Certifications & Licensure
UT State Medical License 2012 - 2026
VA State Medical License 2011 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- (PATHFINDER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, in Patients With Advanced Systemic Mastocytosis Start of enrollment: 2018 Nov 21
- (EXPLORER) Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (AdvSM) and Relapsed or Refractory Myeloid Malignancies Start of enrollment: 2016 Mar 10
- (PIONEER) Study to Evaluate Efficacy and Safety of Avapritinib (BLU-285), A Selective KIT Mutation-targeted Tyrosine Kinase Inhibitor, Versus Placebo in Patients With Indolent Systemic Mastocytosis Start of enrollment: 2019 Apr 16
- Join now to see all
Publications & Presentations
PubMed
- Management of Advanced Systemic Mastocytosis and Associated Myeloid Neoplasms.Tsewang Tashi, Deininger, M.> ;Immunology and Allergy Clinics of North America. 2023 Nov 1
- 6 citationsAvapritinib versus Placebo in Indolent Systemic Mastocytosis.Gotlib, J., Castells, M., Elberink, H., Siebenhaar, F., Hartmann, K., Broesby-Olsen, S., George, T., Panse, J., Alvarez-Twose, I., Radia, D., Tashi, T., Bulai Lividean...> ;NEJM Evidence. 2023 Jun 1
- 2 citationsTrends in overall mortality among US veterans with primary myelofibrosis.Tsewang Tashi, Jingbo Yu, Shivani Pandya, Christopher Dieyi, Robyn Scherber, Shreekant Parasuraman> ;BMC Cancer. 2023 Jan 14
- Join now to see all
Professional Memberships
- Member
- Member
- Member
Other Languages
- Chinese (Mandarin), Hindi, Urdu, French, Taiwanese
Hospital Affiliations
George E. Wahlen Department of Veterans Affairs Medical CenterSalt Lake City, Utah
University of Utah HealthSalt Lake City, Utah
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
